Table of Contents Table of Contents
Previous Page  118 / 1835 Next Page
Information
Show Menu
Previous Page 118 / 1835 Next Page
Page Background

Background

Previous approaches

Brentuximab Vedotin

Immunecheckpoint Inhibitors

Summary

Relapsed and refractory HL